Paolieri F, Pronzato C, Battifora M, Fiorino N, Canonica G W, Bagnasco M
Servizio di Allergologia e Immunologia Clinica Centro di Immunoendocrinologia DI.M.I.-Università di Genova, Italy.
J Endocrinol Invest. 1995 Apr;18(4):295-8. doi: 10.1007/BF03347816.
In the present study we have evaluated the expression of different molecular forms of the antigen receptor (TcR) on lymphocytes derived from thyroid tissue of patients with Graves' disease, Hashimoto thyroiditis and papillary cancer both in situ by APAAP technique and on isolated lymphocytes by indirect immunofluorescence. A panel of monoclonal antibodies (mAbs) recognizing alpha/beta and gamma/delta TcR-positive subsets was used. The results showed that the large majority of T-cells in thyroid infiltrates were alpha/beta TcR+, gamma/delta TcR+ ones being very rare or nearly absent, whatever the disease (autoimmune or neoplastic). No difference between gamma/delta TcR+ T-cell subsets (V delta 1+ or V delta 2+) was observed. Thus, neither in autoimmune thyroid diseases nor in papillary cancer gamma/delta TcR+ cells are likely to be a major effector-T cell population.
在本研究中,我们通过APAAP技术原位评估了Graves病、桥本甲状腺炎和乳头状癌患者甲状腺组织来源淋巴细胞上抗原受体(TcR)不同分子形式的表达,并通过间接免疫荧光法评估了分离淋巴细胞上的表达。使用了一组识别α/β和γ/δ TcR阳性亚群的单克隆抗体(mAb)。结果显示,无论疾病类型(自身免疫性或肿瘤性)如何,甲状腺浸润中的绝大多数T细胞为α/β TcR阳性,γ/δ TcR阳性的细胞非常罕见或几乎不存在。未观察到γ/δ TcR阳性T细胞亚群(Vδ1+或Vδ2+)之间的差异。因此,在自身免疫性甲状腺疾病和乳头状癌中,γ/δ TcR阳性细胞都不太可能是主要的效应T细胞群体。